Percutaneous device closure of patent foramen ovale (PFO) is coming into favour as a secondary preventive measure in patients with cryptogenic stroke. Writing in the MJA, clinicians from St Vincent’s Hospital Melbourne said evidence for a reduction in recurrent stroke following PFO closure has strengthened in recent years. They said trials such as CLOSE, Gore ...
New trials change management of young patients cryptogenic stroke
By Mardi Chapman
24 Oct 2019